Arena Pharmaceuticals (ARNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARNA | BMY | AMGN | GILD | MRNA |
| Company | Arena Pharmaceuticals | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 99.97 | 44.75 | 312.89 | 64.72 | 120.75 |
| High | 100.00 | 44.88 | 314.89 | 66.20 | 124.90 |
| Low | 99.97 | 44.62 | 310.87 | 64.67 | 118.01 |
| Last | 99.99 | 44.72 | 313.45 | 65.83 | 119.25 |
| Change | +0.06 | -0.02 | +0.59 | +1.25 | -3.44 |
| % Change | +0.06% | -0.04% | +0.19% | +1.94% | -2.80% |
| Volume | 5,718,500 | 1,657,549 | 934,561 | 3,731,339 | 1,935,203 |
| 20-Day Average Volume | 1,676,465 | 13,803,103 | 2,843,451 | 7,333,230 | 3,284,367 |
| Previous Close | 99.93 | 44.74 | 312.86 | 64.58 | 122.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 94.81 | 46.00 | 281.76 | 65.99 | 112.06 |
| 20-Day Raw Stochastic | 99.86% | 24.04% | 84.90% | 37.58% | 68.84% |
| 20-Day Relative Strength | 75.07% | 36.25% | 68.17% | 39.41% | 60.20% |
| Weighted Alpha | -14.40 | -34.51 | +35.89 | -19.43 | +6.09 |
| Today's Opinion | 100% Buy | 100% Sell | 56% Buy | 100% Sell | 100% Buy |
| Previous Opinion | 100% Buy | 100% Sell | 56% Buy | 100% Sell | 100% Buy |
| Last Month's Opinion | 100% Buy | 56% Sell | 40% Sell | 100% Sell | 88% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.34% since 03/03/22 | +1.91% since 05/03/24 | +0.63% since 05/03/24 | +1.70% since 05/03/24 | -4.31% since 05/03/24 |
| Low | 93.54 on 03/07/22 | 43.49 on 05/09/24 | 297.52 on 05/06/24 | 64.34 on 05/06/24 | 118.01 on 05/10/24 |
| High | 100.00 on 03/10/22 | 44.88 on 05/10/24 | 314.89 on 05/10/24 | 66.14 on 05/07/24 | 125.50 on 05/09/24 |
| 1-Month | |||||
| %Chg | +6.37% since 02/10/22 | -10.86% since 04/10/24 | +17.56% since 04/10/24 | -3.29% since 04/10/24 | +11.64% since 04/10/24 |
| Low | 92.85 on 02/22/22 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 99.30 on 04/22/24 |
| High | 100.00 on 03/10/22 | 50.58 on 04/11/24 | 322.60 on 05/03/24 | 69.03 on 04/11/24 | 128.81 on 05/02/24 |
| 3-Month | |||||
| %Chg | +100.22% since 12/10/21 | -10.00% since 02/09/24 | +7.60% since 02/09/24 | -10.57% since 02/09/24 | +36.84% since 02/09/24 |
| Low | 89.03 on 01/25/22 | 43.33 on 05/02/24 | 260.68 on 04/19/24 | 64.33 on 05/03/24 | 84.06 on 02/13/24 |
| High | 100.00 on 03/10/22 | 55.03 on 03/13/24 | 322.60 on 05/03/24 | 76.21 on 03/11/24 | 128.81 on 05/02/24 |
| 6-Month | |||||
| %Chg | +68.36% since 09/10/21 | -11.42% since 11/10/23 | +17.19% since 11/10/23 | -13.22% since 11/10/23 | +70.76% since 11/10/23 |
| Low | 48.12 on 12/06/21 | 43.33 on 05/02/24 | 260.52 on 11/21/23 | 64.33 on 05/03/24 | 67.62 on 11/13/23 |
| High | 100.00 on 03/10/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 128.81 on 05/02/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 6,165,283 | 90,692,464 | 167,829,040 | 80,407,072 | 47,019,716 |
| Shares Outstanding, K | 61,659 | 2,027,100 | 536,435 | 1,245,077 | 383,240 |
| Annual Sales | 50,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -616,430,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 50,000 | 11,865,000,000 | 7,447,000,000 | 6,686,000,000 | 167,000,000 |
| Last Quarter Net Income | -155,610,000 | -11,911,000,000 | -113,000,000 | -4,170,000,000 | -1,175,000,000 |
| 60-Month Beta | 0.55 | 0.45 | 0.60 | 0.22 | 1.57 |
| Per-Share Information | |||||
| Most Recent Earnings | -2.54 on 02/23/22 | -4.40 on 04/25/24 | 3.96 on 05/02/24 | -1.32 on 04/25/24 | -3.07 on 05/02/24 |
| Latest Earnings Date | 05/04/22 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 06/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 41.59 | 16.50 | 16.11 | 0.00 |